Study finds gout drug may reduce risk of death

Study finds gout drug may reduce risk of death

In a recently to be published study in Annals of the Rheumatic Diseases, researchers have found the use of the drug allopurinol was associated with a reduced risk of death in hyperuricemic (gout) patients. The study, the first in a general population, has found the...
Stroke patients may benefit from new routines

Stroke patients may benefit from new routines

People who have suffered a stroke often experience severe fatigue. But doctors find it hard to help these patients as their experiences of fatigue may not necessarily be caused by physiological problems. New research from University of Copenhagen suggests that dreams...
How seeing the same doctor helps your health

How seeing the same doctor helps your health

Patients are more likely to raise a health problem with a doctor they’ve seen over time and have built-up a relationship with, new research has revealed. The insight comes as an increasing number of patients struggle to see the same GP. Researchers from the...
Well-child visits make lots of kids sick

Well-child visits make lots of kids sick

New research shows that well-child doctor appointments for annual exams and vaccinations are associated with an increased risk of flu-like illnesses in children and family members within two weeks of the visit. This risk translates to more than 700,000 potentially...
Sedation before nerve block increases risk, not pain relief

Sedation before nerve block increases risk, not pain relief

New research suggests that sedating patients before a nerve block needed to diagnose or treat chronic pain increases costs, risks and unnecessary surgeries, and sedation does nothing to increase patient satisfaction or long-term pain control. “Sedation...
Exercise Improves Depression In Parkinson’s

Exercise Improves Depression In Parkinson’s

A new study by a movement disorder neurologist at The Ohio State University Wexner Medical Center found that depression improved among patients with Parkinson’s disease who participated in a long-term group exercise program. The findings are published in the journal...
New hepatitis C drug shows potential in phase 2 trials

New hepatitis C drug shows potential in phase 2 trials

The addition of danoprevir to the current treatment regimen for patients with hepatitis C leads to high rates of remission, according to a new article in Gastroenterology, the official journal of the American Gastroenterological Association. The current standard of...

Get more stuff like this
in your inbox

Subscribe to our mailing list and get interesting stuff and updates to your email inbox.